A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Condition(s):Acquired Thrombotic Thrombocytopenic PurpuraLast Updated:July 17, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Acquired Thrombotic Thrombocytopenic PurpuraLast Updated:July 17, 2019Unknown status
Condition(s):Factor XIII DeficiencyLast Updated:October 12, 2012Completed
Condition(s):Coronary Artery DiseaseLast Updated:March 13, 2017Unknown status
Condition(s):Diabetic Retinopathy; Posterior Vitreous Detachment; Disease ProgressionLast Updated:December 16, 2020Terminated
Condition(s):Antiplatelet DrugLast Updated:May 28, 2020Suspended
Condition(s):VitrectomyLast Updated:December 17, 2014Completed
Condition(s):Vitreomacular TractionLast Updated:December 17, 2014Completed
Condition(s):VitrectomyLast Updated:December 17, 2014Completed
Condition(s):Stroke, AcuteLast Updated:November 7, 2014Completed
Condition(s):Arterial Occlusive DiseasesLast Updated:April 7, 2014Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.